Obtaining the Japanese Pharmaceutical Wholesale License: Building a Compliant Medical Trade Channel

Chiundo Co., Ltd. has recently been granted a Pharmaceutical Wholesale License issued by the Japanese government. This milestone not only represents an important qualification in the field of pharmaceuticals and healthcare but also reflects the company’s long-standing commitment to compliance, professionalism, and operational excellence.

The acquisition of this license means that Chiundo can now legally engage in the wholesale and import/export of pharmaceuticals, Kampo medicines, and medical devices, thereby offering global clients safer and more reliable services.

Compliance at the Core of International Pharmaceutical Trade

In international pharmaceutical trade, compliance is the most critical requirement. The issuance of a wholesale license mandates that an enterprise must possess proper facilities, a standardized management system, and a qualified professional team. Leveraging years of expertise and proven capabilities in pharmaceutical distribution, Chiundo successfully passed the necessary reviews, further demonstrating the company’s strength in the healthcare sector.

This qualification not only secures the company’s operations within the Japanese domestic market but also provides a solid legal foundation for its cross-border activities. Moving forward, Chiundo will leverage this license to expand collaborations with pharmaceutical manufacturers, health supplement producers, and medical device companies in Japan and overseas. The company aims to provide integrated services covering product sourcing, regulatory filings, GMP consulting, and cross-border exports.

Driving Growth Through Integrated Capabilities

At the same time, Chiundo will continue to leverage its expertise in intellectual property, OEM/ODM partnerships, and cross-border logistics to deliver end-to-end solutions that comply with international regulations.

The company firmly believes that the pharmaceutical and healthcare business is not only about commercial value but also about improving lives and well-being across the globe. Under the principle of strict compliance, Chiundo will continue to explore new models of collaboration and contribute to advancing the pharmaceutical and healthcare industries in Asia toward broader international development.